FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to perorally introduced product in form of viscosified drink, which is capable of stimulating swallowing reflex in an individual, containing thickening agent and at least one vanilloid receptor (VR-1) agonist, selected from group consisting of: capsiate, dihydrocapsaicine, nordihydrocapsaicine dihydrocapsiate, nordihydrocapsiate, homocapsaicine, homodihydro-capsaicine, vanillyl amyl n-nonanoic acid (VNA), anandomide, resiniferatoxin and olvanil. Product can also be liquid or with modified structure. Invention also relates to product application for prevention or treatment of oropharyngeal dysphagia in an individual.
EFFECT: invention ensures increased safety of swallowing, improvement of swallowing response time and reduction of side effects, associated with intake of vanilloid receptor antagonists, such as burning sensation, dizziness, nausea, vomiting, and shortness of breath.
21 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSING NEUROGENIC PERIPHERAL DYSPHAGIA WITH LIMITED MOBILITY OF LARYNX UNDER THE CONTROL OF TRANSNASAL ENDOSCOPIC LARYNGOSCOPY | 2020 |
|
RU2748545C1 |
THICKENED COMPOSITION FOR PATIENTS WITH DYSPHAGIA | 2018 |
|
RU2800954C2 |
METHOD FOR SCREENING EVALUATION OF SWALLOWING FUNCTION IN PATIENTS WITH CHRONIC IMPAIRMENT OF CONSCIOUSNESS | 2021 |
|
RU2774605C1 |
RAPIDLY DISSOLVING MEDICATION-RELEASING SYSTEMS | 2011 |
|
RU2560693C2 |
METHOD OF TREATING CRICOPHARYNGEAL INSUFFICIENCY AND RECUPERATION OF SWALLOWING FUNCTION | 2019 |
|
RU2714177C1 |
AGENT AND FOOD STUFF FOR PREVENTION/SUPPRESSION OF FUNCTIONAL DYSPEPSIA | 2005 |
|
RU2407524C2 |
METHOD FOR CORRECTION OF NEUROGENIC DISORDERS OF FOOD INTAKE PROCESS OF PERIPHERAL GENESIS IN POSTOPERATIVE PARESIS AND LARYNGEAL PARALYSIS | 2019 |
|
RU2723604C1 |
PRELIMINARILY THICKENED COMPACT LIQUID NUTRITIONAL COMPOSITION FOR PATIENTS WITH DYSPHAGIA | 2011 |
|
RU2564913C2 |
THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS | 2013 |
|
RU2655811C2 |
METHOD FOR RESTORING SWALLOWING AND PHONATION IN PATIENTS WITH ACUTE CEREBROVASCULAR DISORDERS | 0 |
|
SU1683774A1 |
Authors
Dates
2013-05-20—Published
2008-10-07—Filed